ONCTERNAL THERAPEUTICS INC (ONCT)
US68236P2065 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 6.70M | 37.10M | 90.80M | 116.70M | 20.10M | |||
| Marketable Securities | 27.56M | 26.60M | N/A | N/A | N/A | |||
| Receivables | 632.00K | 200.00K | N/A | N/A | N/A | |||
| Other Current Assets | 1.17M | 3.40M | 2.10M | 1.30M | 700.00K | |||
| Total Current Assets | 36.06M | 67.30M | 92.90M | 118.00M | 20.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 258.00K | 100.00K | 100.00K | 0.00 | 200.00K | |||
| Intangibles | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 412.00K | 1.30M | 700.00K | 800.00K | 800.00K | |||
| Total Non-Current Assets | 670.00K | 1.40M | 700.00K | 800.00K | 900.00K | |||
| TOTAL ASSETS | 36.73M | 68.70M | 93.60M | 118.80M | 21.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 4.05M | 4.80M | 3.50M | 3.10M | 2.80M | |||
| Accounts Payable | 1.15M | 2.90M | 2.00M | 1.10M | 900.00K | |||
| Other Current Liabilities | N/A | N/A | 0.00 | 1.60M | 3.60M | |||
| Total Current Liabilities | 5.20M | 7.70M | 5.50M | 5.90M | 7.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 1.48M | N/A | N/A | 0.00 | 100.00K | |||
| Total Non-Current Liabilities | 1.48M | 0.00 | 0.00 | 0.00 | 100.00K | |||
| TOTAL LIABILITIES | 6.68M | 7.70M | 5.50M | 5.90M | 7.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -197.78M | -158.30M | -114.10M | -82.80M | -65.60M | |||
| Additional Paid In Capital | 227.82M | 219.20M | 202.20M | 195.70M | 79.90M | |||
| Common Shares | 3.00K | 100.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 3.00K | 0.00 | N/A | N/A | N/A | |||
| Shares Outstanding | 2.95M | 57.50M | 49.40M | 48.80M | 15.40M | |||
| Tangible Book Value per Share | 10.19 | 1.06 | 1.78 | 2.32 | 0.93 | |||
| Total Shareholders' Equity | 30.05M | 61.00M | 88.10M | 113.00M | 14.30M | |||
| TOTAL LIABILITIES AND EQUITY | 36.73M | 68.70M | 93.60M | 118.80M | 21.70M | |||
| Statistics | ||||||||
| Current Ratio | 6.94 | 8.74 | 16.89 | 20.00 | 2.85 | |||
| Return On Assets (ROA) | -107.49% | -64.29% | -33.47% | -14.50% | -157.56% | |||
| Return On Equity (ROE) | -131.37% | -72.41% | -35.56% | -15.25% | -239.09% | |||
All data in USD